Reference | Intervention/exposure | Group size, n | Age, mean (SD) | Male, % | CCI, mean (SD) | SOFA scorea, mean (SD) | Invasive ventilation, % | Vasopressor use, % | Mortality, % (days) |
---|---|---|---|---|---|---|---|---|---|
Macdonald et al. [33] | Standard fluid regimen group | 49 | 65 (52,78)b | 62 | 2 (1,4)b | 5 (3,9)b | - | 78 | 8 (90) |
Restricted fluid regimen group | 46 | 66 (45,76)b | 63 | 2 (0,5)b | 5 (4,7)b | - | 53 | 9 (90) | |
Ilyina [34] | Crystalloid fluid bolus (7 mL/kg) | 18 | 55, 16 | 61 | – | 11 | 100 | - | 44 (28) |
Total fluid administration | 86 | 64, 18 | 60 | 3 (1,5)b | 8, 4 | 43 | 64 | 13 (30) | |
Saoraya [31] | Standard fluid regimen group (30Â mL/kg/h) | 48 | 72, 16 | 62 | 5 (4,7)b | 5 (2,6)b | 42c | 42c | 25 (28); 31 (90) |
Limited fluid regimen group (10Â mL/kg/h) | 48 | 70, 18 | 60 | 5 (3,7)b | 4 (2,5)b | 23c | 17c | 17 (28); 19 (90) | |
Hippensteel [30] (A) | Total fluid administration | 56 | 59, 15 | 54 | 3, 3 | 7, 4 | – | – | 9 (in-hospital) |
Hippensteel [30] (B) | Total fluid administration | 100 | 61, 3 | 66 | 4, 3 | 4, 4 | – | – | 11 (in-hospital) |
Inkinen [29] | Total fluid administration | 619 | 66 (55,75)b | 64 | – | 8 (6,10)b | 65 | 71 | 29 (90) |
Pouska et al. [36] | Fast fluid bolus (5–10 min) | 25 | 61, 18 | 43 | – | 10 (7,14)b | – | 86 | – |
Slow fluid bolus (25–30 min) | 9 | 57, 19 | 67 | – | 8 (8,12)b | – | 89 | – | |
Smart [35] | 10 ml/kg 0.9% NaCl | 34 | 45 (39,52)b | 58 | 0 (0,1)b | 0 (0,1)b | – | 3 | 3 (30) |
5 ml/kg 3% NaCl | 36 | 41 (35,47)b | 62 | 0 (0,1)b | 0 (0,1)b | – | 0 | 3 (30) | |
Smart [28] | Total fluid administration | 86 | 59 (52,66)b | 59 | 2 (1,4)b | 4 (3,6)b | – | – | 19 (30) |
Wu [27] | Total fluid administration | 15 | 65, 10 | 73 | – | 6, 3 | – | – | 27 (in-hospital) |